Pistachio Group for Macular Degeneration
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on lipid-lowering medication, you can participate as long as you continue your current regimen throughout the study.
What data supports the effectiveness of the Pistachio Group treatment for macular degeneration?
How is the Pistachio Group treatment different from other treatments for macular degeneration?
The Pistachio Group treatment may be unique due to its potential focus on dietary components, as research suggests that antioxidants found in foods like fruits, vegetables, and nuts can influence macular health. This approach might differ from standard treatments that often involve medications or injections.56789
What is the purpose of this trial?
This trial tests if eating pistachios can help older adults by protecting their eyes from light damage and improving brain function. Pistachios contain nutrients that are beneficial for eye and brain health. Pistachios contain protein, carbohydrate, dietary fibers, fat, folic acid, vitamin K, magnesium and potassium, gama-tocopherols, phytochemicals, and polyphenols, which have antioxidant and anti-inflammatory functions.
Research Team
Tammy Scott
Principal Investigator
Tufts University
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive pistachio nuts in 2-ounce packs daily for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Pistachio Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tufts University
Lead Sponsor
American Pistachio Growers
Collaborator